25%
India carries a quarter of the global TB burden, yet patients delay presentation until symptoms become severe and irreversible.
Acoustic AI Screening
TB. COPD. Asthma.
Detected from a Cough on Any Smartphone.
No specialised hardware. Trained on real Indian OPD conditions, not a laboratory.
The problem
Respiratory Disease in India Is Caught Too Late.
Acoustic biomarkers in a cough carry clinically significant diagnostic signal. Yet no screening model has been built for the real conditions of clinical deployment.
55M+
Indians live with chronic obstructive airway disease, overwhelmingly undiagnosed until permanent lung damage has occurred.
Lab ≠ Field
Prior acoustic models trained in clean laboratory settings collapse when exposed to ambient OPD noise, consumer microphones and network audio compression.
How it works
One Cough. An Objective Risk Score.
Designed for point-of-first-contact triage through low-bandwidth voice messaging, with zero app installation required.
01 Capture Cough Audio
A short voluntary recording sent via standard mobile voice messaging. No new software to install.
02 Acoustic Feature Extraction
Log-Mel spectrogram features are extracted and evaluated against models trained on molecularly and objectively confirmed clinical ground truth.
03 Physician Decision Support
Elevated-risk individuals are prioritised for confirmatory diagnostics (GeneXpert or spirometry) earlier in their disease trajectory. Pre-screening only; diagnosis remains strictly with clinicians.
Zero new infrastructure
The Deployment Infrastructure Is Already in Every Pocket.
Designed to deploy at national scale without creating a single procurement or operational barrier.
No App Download
No Dedicated Hardware
No Upfront CapEx
No High-Speed Data
The vision
Starting with TB. Scaling Across All Respiratory Disease.
A single national acoustic dataset and multimodal AI architecture engineered to generalise across clinical phenotypes and geographies.
- 01
Starts with TB
India's highest-burden infectious respiratory disease. Our initial disease-specific model targets presumptive TB triage anchored to molecular ground truth.
- 02
Differential Airway Triage
Simultaneous risk stratification for COPD, asthma and acute lower respiratory conditions from the same audio capture.
- 03
National Generalisability
Recruited across six distinct epidemiological zones to ensure models perform robustly across regional acoustic and demographic variance.
We are not building a screening tool for a single clinic. We are building the acoustic respiratory intelligence layer for India.
Work with us
We're Looking for the Right Partners.
Hospitals & Clinics
Chest and pulmonary OPDs as research sites. We fund and staff everything, you get named co-authorship and priority model access.
Network & Introductions
Warm introductions to hospital CMOs, medical directors or health department decision-makers move faster than cold outreach.
Academic & Research
Medical institutions interested in clinical validation partnerships, co-authorship or joint grant applications in respiratory AI.
Strategic Investors
Investors who understand the Indian healthcare market and bring clinical relationships alongside capital. Pre-seed round open.
India's Respiratory Disease Burden Demands Earlier Detection.
Whether you lead a chest OPD, oversee a hospital department, invest in clinical deep-tech, or want to explore research collaboration, connect with us.